Aldeyra Therapeutics, Inc. · NASDAQ:ALDX
Perceptive Advisors LLC reported a 7.00% stake in Aldeyra Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Perceptive Advisors LLC reported a 7.00% stake in Aldeyra Therapeutics, Inc., 4,185,632 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 7.00%
- Shares
- 4,185,632
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Perceptive Advisors LLC | 7.00% | 4,185,632 |
| Joseph Edelman | 7.00% | 4,185,632 |
| Perceptive Life Sciences Master Fund, Ltd. | 7.00% | 4,185,632 |
Source
Related
- Aldeyra Therapeutics, Inc.
- Perceptive Advisors LLC
- Aldeyra Therapeutics, Inc. shareholders
- Schedule 13G/A · Perceptive Advisors LLC · May 15, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Nov 14, 2025
- Schedule 13G/A · Perceptive Advisors LLC · Aug 14, 2025
- Schedule 13G/A · Perceptive Advisors LLC · Apr 7, 2025
- Schedule 13G · AQR Capital Management LLC · Aug 12, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Brady Todd C · Jun 5, 2026
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026